Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

11.54
Data as of Sep 22
 -0.46 / -3.83%
Today’s Change
5.70
Today|||52-Week Range
19.25
-7.01%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Repella Robert
Chief Commercial Officer & Senior Vice President
Sale11/21/201364,100$12.12$776.9K-3.91%
Watkins H Thomas
Director
Sale3/14/201435,000$17.66$618.1K-34.62%
Repella Robert
Chief Commercial Officer & Senior Vice President
Sale11/20/201340,515$11.89$481.7K-0.69%
Watkins H Thomas
Director
Buy3/14/201435,000$9.40$329.0K-34.62%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale2/18/201417,772$13.46$239.2K-14.83%
Repella Robert
Chief Commercial Officer & Senior Vice President
Buy11/20/201340,515$5.90$239.0K-0.69%
Repella Robert
Chief Commercial Officer & Senior Vice President
Buy11/21/201323,040$5.90$135.9K-3.91%
Repella Robert
Chief Commercial Officer & Senior Vice President
Buy11/21/201334,570$3.12$107.9K-3.91%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale11/19/20138,928$12.07$107.8K-3.75%
Kelly James Patrick
Secretary, Treasurer & Chief Financial Officer
Sale2/18/20147,124$13.46$95.9K-14.83%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.